Company Quick10K Filing
Quest Patent Research
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.00 383 $8
10-K 2020-03-27 Annual: 2019-12-31
10-Q 2019-11-14 Quarter: 2019-09-30
10-Q 2019-08-14 Quarter: 2019-06-30
10-Q 2019-05-15 Quarter: 2019-03-31
10-K 2019-04-16 Annual: 2018-12-31
10-Q 2018-11-14 Quarter: 2018-09-30
10-Q 2018-08-14 Quarter: 2018-06-30
10-Q 2018-05-15 Quarter: 2018-03-31
10-K 2018-04-02 Annual: 2017-12-31
10-Q 2017-11-14 Quarter: 2017-09-30
10-Q 2017-08-11 Quarter: 2017-06-30
10-Q 2017-05-12 Quarter: 2017-03-31
10-K 2017-04-17 Annual: 2016-12-31
10-Q 2016-11-14 Quarter: 2016-09-30
10-Q 2016-08-12 Quarter: 2016-06-30
10-Q 2016-05-13 Quarter: 2016-03-31
10-K 2016-04-01 Annual: 2015-12-31
10-Q 2015-11-09 Quarter: 2015-09-30
10-Q 2015-10-01 Quarter: 2015-06-30
10-Q 2015-10-01 Quarter: 2015-03-31
10-K 2015-08-18 Annual: 2014-12-31
10-Q 2015-09-24 Quarter: 2014-09-30
10-Q 2015-09-24 Quarter: 2014-06-30
10-Q 2015-09-24 Quarter: 2014-03-31
10-K 2015-04-10 Annual: 2013-12-31
10-Q 2015-02-09 Quarter: 2013-06-30
10-Q 2015-02-09 Quarter: 2013-06-30
10-Q 2015-02-09 Quarter: 2013-03-31
10-K 2014-12-15 Annual: 2012-12-31

Quest Patent Research Financials

QPRC Metrics, Comps, Filings

Annual | Quarterly

Business

We are an intellectual property asset management company. Our principal operations include the development, acquisition, licensing and enforcement of intellectual property rights that are either owned or controlled by us or one of our wholly-owned subsidiaries. We currently own, control or manage eleven intellectual property portfolios, which principally consist of patent rights. Our eleven intellectual property portfolios include the portfolios which we acquired from Intellectual Ventures Assets 16, LLC (“Intellectual Ventures”) and seven of its affiliates. As part of our intellectual property asset management activities and in the ordinary course of our business, it has been necessary for us or the intellectual property owner who we represent to initiate, and it is likely to continue to be necessary to initiate, patent infringement lawsuits and engage in patent infringement litigation. We anticipate that our primary source of revenue will come from the grant of licenses to use our intellectual property, including licenses granted as part of the settlement of patent infringement lawsuits. We also generated revenue from management fees from managing intellectual property portfolios in 2017, although we do not currently receive these fees and we do not have any agreements that provide for such payments.

- Patent licensing fees relating to our intellectual property portfolio, which includes fees from the licensing of our intellectual property, primarily from litigation relating to enforcement of our intellectual property rights. - Management fees, which we receive for managing structured licensing programs, including litigation, related to our intellectual property rights, although we do not currently receive these fees and do not have any agreements that provide for such payments. - Licensed packaging sales, which relate to the sale of licensed products.

Intellectual property monetization includes the generation of revenue and proceeds from the licensing of patents, patented technologies and other intellectual property rights. Patent litigation is often a necessary element of intellectual property monetization where a patent owner, or a representative of the patent owner, seeks to protect its patent rights against the unlicensed manufacture, sale, and use of the owner's patent rights or products which incorporate the owner's patent rights. In general, we seek to monetize the bundle of rights granted by the patents through structured licensing and when necessary enforcement of those rights through litigation, although to date all of our patent license revenues have resulted from litigation.


Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Stockholders' Equity

Income Statement ($MM Annual)

Revenue, Gross Profit, Net Income

Cash Flow ($MM Annual)

Operating, Investing, Financing

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
PetVivo Holdings (PETV) 8,652 -3.8 -453% 648 1,447 0 -82 -2,937 -2,243 8,632
Life On Earth (LFER) 4,120 29% -0.8 -943% 827 4,357 -313 -90 -7,797 -6,554 5,170
Accelerize (ACLZ) 7,974 59% 0.6 264% 4,998 790 5,458 3,213 13,190 13,245 7,482
Wright Investors (WISH) 7,898 -4.1 -18% 7,976 105 0 0 -1,464 -1,438 5,899
Giga Tronics (GIGA) 8,058 42% 735.4 -4% 8,753 6,345 11,951 5,069 -379 10 7,354
Janel (JANL) 9,201 30% 8.8 1% 55,266 39,850 63,607 18,943 689 1,329 11,652
Citadel Exploration (COIL) 7,833 0% -3.8 -40% 5,933 7,408 279 0 -2,363 -1,983 7,627
Torotel (TTLO) 8,394 39% 4.4 18% 12,289 6,879 25,942 10,206 2,253 2,439 10,746
Quest Patent Research (QPRC) 7,661 31% -46.2 -31% 3,785 9,509 2,028 628 -1,183 -204 9,416
Lithium (LTUM) 7,652 32.1 28% 808 12 0 0 226 226 7,255
Voltari (VLTC) 7,646 0% -82.9 -9% 22,429 27,876 1,584 0 -1,934 -363 30,082
Mentor Capital (MNTR) 3,702 29% -1.0 -59% 5,269 1,972 3,177 930 -3,131 -3,080 2,951
Valuesetters (VSTR) 8,306 99% 6.9 54% 2,193 1,554 1,689 1,671 1,177 1,200 8,275
Capstone Companies (CAPC) 7,501 22% 109.3 0% 6,855 961 11,741 2,576 11 48 5,195
Reshape Lifesciences (RSLS) 92 65% 0.2 -111% 44,183 59,845 11,039 7,190 -49,150 -49,297 -7,625
ForeverGreen (FVRG) 7,387 77% 43.6 -50% 3,316 11,504 11,815 9,132 -1,674 178 7,750
Castle AM (CTAM) 7,373 0% 45.0 -8% 346,985 382,366 433,570 0 -28,503 5,827 261,951
Sonic Foundry (SOFO) 7,343 73% -4.2 -24% 15,180 21,433 34,781 25,501 -3,612 -2,241 9,445
Ethema Health (GRST) 7,193 0% -1.2 -32% 23,469 33,429 599 0 -7,507 -6,127 7,192
Fision (FSSN) 7,467 85% -1.7 -314% 1,589 5,112 376 320 -4,992 -4,983 8,249

Balance Sheet ($'000)2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-31
Cash190923322081661670
Accounts Receivable64224255300
Inventory0
PP&E0
Assets24201162,6982,3232,6342,2150
Accounts Payable00
Long-Term Debt1,2500
Liabilities3,5284,3694702,8783,6595,0616,7540
Stockholders' Equity-3,507-4,352-356-183-1,339-2,430-4,5410
Income Statement ($'000)2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-31
Revenue4330233318147,0690
Cost of Revenue78223696,0720
Gross Profit183525729970
R&D00
SG&A8009027135627679399580
Tax1221061,0400
Net Income-638-871-162-327-956-1,167-2,1120
Cash Flow ($'000)2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-31
Cash Operating0-892-199-373-168-3790
Cash Investing-110-200
Cash Financing-244392501254000